Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions

    Servier recently announced that Voranigo ®also won thePrix GalienUSAAward  in the Best Product for Orphan/Rare Diseases category, as well as thePrix Galien Poland Award. ThePrix GalienAward recognizes breakthrough products and outstanding research teams across the pharmaceutical, biotech, medtech, and digital health fields. "We are truly honored to receive these prestigious distinctions in several countries. It recognizes the scientific progress that Voranigo®...

USA, 08/12/2025 (informazione.news - comunicati stampa - salute e benessere)

 

Servier recently announced that Voranigo^® also won the Prix Galien USA Award in the Best Product for Orphan/Rare Diseases category, as well as the Prix Galien Poland Award.

The Prix Galien Award recognizes breakthrough products and outstanding research teams across the pharmaceutical, biotech, medtech, and digital health fields.

"We are truly honored to receive these prestigious distinctions in several countries. It recognizes the scientific progress that Voranigo^® can bring to patients living with glioma across the world", said Arnaud Lallouette, Executive Vice-President, Global Medical & Patient Affairs. "It rewards Servier's commitment to innovation and to patients as we continue to advance precision oncology for all who stand to benefit."

Voranigo^® has been granted marketing authorization for the treatment of predominantly non-enhancing Grade 2 astrocytoma or oligodendroglioma with an isocitrate dehydrogenase-1 (IDH1) R132 or isocitrate dehydrogenase-2 (IDH2) R172 mutation in adult and adolescent patients aged 12 years and older and weighing at least 40 kg who only had surgical intervention and who are not in immediate need of radiotherapy or chemotherapy. in the United States, Canada, Australia, Israel, the United Arab Emirates, Saudi Arabia, Switzerland, Brazil, the United Kingdom, in Japan and Europe (27 countries of the European Union as well as Iceland, Liechtenstein and Norway).

Press Contact
presse@servier.com 

About Servier 
Servier is an independent international pharmaceutical company. To find out more please visit the Group website: servier.com
Follow us on social media: LinkedIn, Facebook, X, Instagram 

References  

Logo: https://mma.prnewswire.com/media/2766991/5496713/Servier_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/serviers-voranigo-vorasidenib-receives-prix-galien-awards-across-multiple-regions-302635240.html